Gradient Dissent: Conversations on AI cover image

Accelerating drug discovery with AI: Insights from Isomorphic Labs

Gradient Dissent: Conversations on AI

CHAPTER

AI in Drug Discovery: Enhancing Molecule Development

The chapter explores the potential of machine learning in drug discovery, discussing its role in developing molecules for clinical trials. It highlights the advancements in AI that can broaden the pool of candidate medicines and increase the success rate of drugs passing through development pipelines. The dialogue emphasizes the collaborative effort between chemists and machine learning engineers to tackle complex challenges in visualizing molecular data and integrating technology for real-world solutions.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner